Explore opportunities with Novartis and Sandoz below. For additional roles with Novartis Gene Therapies (formerly AveXis) visit the GTx Career Search.

Ontario is the first province in Canada to offer public reimbursement for Pluvicto™, a targeted radioligand therapy for patients with progressive PSMA-positive metastatic castration-resistant prostate ...

Scottish Medicines Consortium (SMC) has recommended Fabhalta® (iptacopan) as monotherapy for adults with paroxysmal nocturnal haemoglobinuria (PNH) who have haemolytic anaemia and used under the ...

Job Title Sort ascending Business Location Site Date Posted Assistant Manager - ERP Assurance Regular, Full time CTS India Hyderabad (Office) Jan 21, 2025 Employee Relations Lead Regular, Full time ...

We will listen to different communities with a learning mindset to do what we can to contribute to building a world that is safer and more inclusive. At Novartis, we celebrate life and recognize ...

This collaborative working project aims to improve the capacity within the Collaborative Working (CW) Partner’s Multiple Sclerosis (MS) service in Greater Manchester through the expansion of the ...

Below is a list of the treatments we currently offer via our Innovative Medicines Division. Visit Sandoz and Advanced Accelerator Applications to learn about our generics and radiopharmaceutical ...

The collaborative working project (CWP) is a proof of concept with the aim to redesign the CW Partner’s multiple sclerosis (MS) service with the addition of an MS disease modifying therapy (DMT) ...

Falin Ishwarlal Majmudar has 31+ years of experience in Medical device and Pharmaceutical industry having expertise in Manufacturing, Supply Chain, External Supply Operations (ESO) and Project ...

At Novartis, we have a strong commitment to sustainable development. As a global organization, we recognize the opportunity to drive positive social change. We are on a continuous journey to channel ...